文献速递产科母胎医学

选择性妊娠晚期超声筛查小于胎龄儿后的围产期结局:嵌套于DESiGN随机对照试验的前瞻性队列研究

Perinatal outcomes after selective third-trimester ultrasound screening for small-for-gestational age: prospective cohort study nested within DESiGN randomized controlled trial.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-11-25

本研究嵌套于英国DESiGN试验,纳入165 321例单胎妊娠,评估选择性妊娠晚期超声筛查小于胎龄儿(SGA)假阴性较真阳性、假阳性较真阴性的围产期结局。假阴性较真阳性死产风险显著升高(aOR 1.18),假阳性较真阴性死产风险亦显著升高(aOR 2.24)。作者认为需提高SGA检出以处理假阴性,假阳性病例也是需监测和及时分娩的高危小胎儿人群。

要点

  • 假阴性较真阳性SGA筛查结果死产风险显著升高(aOR 1.18,95%CI 1.07-1.31)。
  • 假阳性较真阴性筛查结果死产风险显著升高(aOR 2.24,95%CI 1.88-2.68)。
  • 假阳性组出生体重百分位中位数18.1低于真阴性组49.9。

核心结论

  • 在选择性妊娠晚期超声筛查SGA中,假阴性结果较真阳性结果死产风险显著升高(aOR 1.18,95%CI 1.07-1.31),假阳性结果较真阴性结果死产风险显著升高(aOR 2.24,95%CI 1.88-2.68)。
  • 作者认为需改进SGA检出以处理假阴性结果,并应认识到假阳性SGA筛查病例也是需要监测和及时分娩的小胎儿高危人群。

研究设计与样本

  • 前瞻性队列研究,嵌套于英国DESiGN试验(前瞻性多中心队列研究),纳入单胎妊娠、无产前检出胎儿畸形、出生孕周>24+0至<43+0周。
  • 纳入试验基线期或对照组、未暴露于生长评估方案(GAP)干预且出生结局已知的孕妇,共165 321例。

主要发现

  • 假阴性较真阳性SGA筛查结果:死产风险显著升高(aOR 1.18,95%CI 1.07-1.31),主要新生儿疾病风险降低(aOR 0.87,95%CI 0.83-0.91),次要新生儿疾病风险降低(aOR 0.56,95%CI 0.54-0.59)。
  • 假阳性较真阴性筛查结果:出生体重百分位中位数18.1(IQR 13.3-26.9) vs 49.9(IQR 30.3-71.7)。
  • 假阳性较真阴性筛查结果:死产风险显著升高(aOR 2.24,95%CI 1.88-2.68),次要新生儿疾病风险显著升高(aOR 1.60,95%CI 1.51-1.71),主要新生儿疾病风险无显著差异(aOR 1.04,95%CI 0.98-1.09)。

关键数值与推荐

  • 疑似SGA定义为基于Hadlock公式和胎儿生长曲线的估计胎儿体重(EFW)<第10百分位。
  • 出生SGA定义为基于英国人群参考的出生体重(BW)<第10百分位。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In screening for small-for-gestational age (SGA) using third-trimester antenatal ultrasound, there are concerns about the low detection rates and potential for harm caused by both false-negative and false-positive screening results. Using a selective third-trimester ultrasound screening program, this study aimed to investigate the incidence of adverse perinatal outcomes among cases with (i) false-negative compared with true-positive SGA diagnosis and (ii) false-positive compared with true-negative SGA diagnosis. METHODS: This prospective cohort study was nested within the UK-based DESiGN trial, a prospective multicenter cohort study of singleton pregnancies without antenatally detected fetal anomalies, born at > 24 + 0 to < 43 + 0 weeks' gestation. We included women recruited to the baseline period, or control arm, of the trial who were not exposed to the Growth Assessment Protocol intervention and whose birth outcomes were known. Stillbirth and major neonatal morbidity were the two primary outcomes. Minor neonatal morbidity was considered a secondary outcome. Suspected SGA was defined as an estimated fetal weight (EFW) < 10th percentile, based on the Hadlock formula and fetal growth charts. Similarly, SGA at birth was defined as birth weight (BW) < 10th percentile, based on UK population references. Maternal and pregnancy characteristics and perinatal outcomes were reported according to whether SGA was suspected antenatally or not. Unadjusted and adjusted logistic regression models were used to quantify the differences in adverse perinatal outcomes between the screening results (false negative vs true positive and false positive vs true negative). RESULTS: In total, 165 321 pregnancies were included in the analysis. Fetuses with a false-negative SGA screening result, compared to those with a true-positive result, were at a significantly higher risk of stillbirth (adjusted odds ratio (aOR), 1.18 (95% CI, 1.07-1.31)), but at lower risk of major (aOR, 0.87 (95% CI, 0.83-0.91)) and minor (aOR, 0.56, (95% CI, 0.54-0.59)) neonatal morbidity. Compared with a true-negative screening result, a false-positive result was associated with a lower BW percentile (median, 18.1 (interquartile range (IQR), 13.3-26.9) vs 49.9 (IQR, 30.3-71.7)). A false-positive result was also associated with a significantly increased risk of stillbirth (aOR, 2.24 (95% CI, 1.88-2.68)) and minor neonatal morbidity (aOR, 1.60 (95% CI, 1.51-1.71)), but not major neonatal morbidity (aOR, 1.04 (95% CI, 0.98-1.09)). CONCLUSIONS: In selective third-trimester ultrasound screening for SGA, both false-negative and false-positive results were associated with a significantly higher risk of stillbirth, when compared with true-positive and true-negative results, respectively. Improved SGA detection is needed to address false-negative results. It should be acknowledged that cases with a false-positive SGA screening result also constitute a high-risk population of small fetuses that warrant surveillance and timely birth. © 2024 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Winsloe C, Elhindi J, Vieira MC, et al. Perinatal outcomes after selective third-trimester ultrasound screening for small-for-gestational age: prospective cohort study nested within DESiGN randomized controlled trial. Ultrasound Obstet Gynecol. 2024. PMID: 39586022. doi:10.1002/uog.29130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。